FDA Announces Approval of Blood Manufacturing Regulations

Summary

The Food and Drug Administration (FDA) has announced that it has received approval from the Office of Management and Budget (OMB) for a collection of information related to Current Good Manufacturing Practices and Related Regulations for Blood and Blood Components, as mandated by the Paperwork Reduction Act of 1995.